IFC extends $147-million loan to Jubilant Pharma
International Finance Corporation (IFC), a member of the World Bank is lending $147.5 million (around Rs.866 crore) to Jubilant Pharma […]
Tags: Asia Pacific, Asia Pacific director, Business/Finance, Canada, Chairman, contract manufacturing, Director, drug discovery, Economics, Economy of India, generic drug manufacturing facilities, health, Health/Medical/Pharmaceuticals, healthcare, healthcare expertise, Healthcare in India, India, international finance corporation, JUBILANT LIFE SCIENCES LIMITED, Jubilant Pharma Limited, Major, manufacturing operations, Pharmaceutical industry in Bangladesh, Pharmaceutical industry in India, Pharmaceutical industry in the People's Republic of China, pharmaceutical sector, pharmaceuticals, quality healthcare, Reorganization, Rs, Shyam S Bhartia, Singapore, United States, USD, World Bank
